The very touchy issue of whether antibiotic use in livestock (they act as growth promoters) should be banned has come up once again in today s Wall Street Journal. Although research and development in the antibiotic field has come back to life, thanks in no small part to ACSH advisor Dr. David Shlaes, it is not nearly enough to make up for the twenty-year hole in the pipeline caused mainly by a terrible policy change at the FDA.
The very touchy issue of whether antibiotic use in livestock (they act as growth promoters) should be banned has come up once again in today s Wall Street Journal. Although research and development in the antibiotic field has come back to life, thanks in no small part to ACSH advisor Dr. David Shlaes, it is not nearly enough to make up for the twenty-year hole in the pipeline caused mainly by a terrible policy change at the FDA.